Biogenic nanoporous silica-based sensor for enhanced electrochemical detection of cardiovascular biomarkers proteins

Kai Chun Lin, Vindhya Kunduru, Manish Bothara, Kaushal Rege, Shalini Prasad, B. L. Ramakrishna

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

The goal of our research is to demonstrate the feasibility of employing biogenic nanoporous silica as a key component in developing a biosensor platform for rapid label-free electrochemical detection of cardiovascular biomarkers from pure and commercial human serum samples with high sensitivity and selectivity. The biosensor platform consists of a silicon chip with an array of gold electrodes forming multiple sensor sites and works on the principle of electrochemical impedance spectroscopy. Each sensor site is overlaid with a biogenic nanoporous silica membrane that forms a high density of nanowells on top of each electrode. When specific protein biomarkers: C-reactive protein (CRP) and myeloperoxidase (MPO) from a test sample bind to antibodies conjugated to the surface of the gold surface at the base of each nanowell, a perturbation of electrical double layer occurs resulting in a change in the impedance. The performance of the biogenic silica membrane biosensor was tested in comparison with nanoporous alumina membrane-based biosensor and plain metallic thin film biosensor. Significant enhancement in the sensitivity and selectivity was achieved with the biogenic silica biosensor, in comparison to the other two, for detecting the two protein biomarkers from both pure and commercial human serum samples. The sensitivity of the biogenic silica biosensor is ∼1 pg/ml and the linear dose response is observed over a large dynamic range from 1 pg/ml to 1 μg/ml. Based on its performance metrics, the biogenic silica biosensor has excellent potential for development as a point of care handheld electronic biosensor device for detection of protein biomarkers from clinical samples.

Original languageEnglish (US)
Pages (from-to)2336-2342
Number of pages7
JournalBiosensors and Bioelectronics
Volume25
Issue number10
DOIs
StatePublished - Jun 2010

Fingerprint

Biosensing Techniques
Biomarkers
Biosensors
Silicon Dioxide
Silica
Proteins
Sensors
Membranes
Gold
Electrodes
Point-of-Care Systems
Dielectric Spectroscopy
Metallic films
Aluminum Oxide
Silicon
Protein C
Serum
Electric Impedance
Electrochemical impedance spectroscopy
Antibodies

Keywords

  • Biogenic silica biosensor
  • Cardiovascular disease
  • Electrochemical impedance spectroscopy
  • Protein biomarker detection

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

Biogenic nanoporous silica-based sensor for enhanced electrochemical detection of cardiovascular biomarkers proteins. / Lin, Kai Chun; Kunduru, Vindhya; Bothara, Manish; Rege, Kaushal; Prasad, Shalini; Ramakrishna, B. L.

In: Biosensors and Bioelectronics, Vol. 25, No. 10, 06.2010, p. 2336-2342.

Research output: Contribution to journalArticle

Lin, Kai Chun ; Kunduru, Vindhya ; Bothara, Manish ; Rege, Kaushal ; Prasad, Shalini ; Ramakrishna, B. L. / Biogenic nanoporous silica-based sensor for enhanced electrochemical detection of cardiovascular biomarkers proteins. In: Biosensors and Bioelectronics. 2010 ; Vol. 25, No. 10. pp. 2336-2342.
@article{a64c7a0c318441aaa3c6b4ac594940f1,
title = "Biogenic nanoporous silica-based sensor for enhanced electrochemical detection of cardiovascular biomarkers proteins",
abstract = "The goal of our research is to demonstrate the feasibility of employing biogenic nanoporous silica as a key component in developing a biosensor platform for rapid label-free electrochemical detection of cardiovascular biomarkers from pure and commercial human serum samples with high sensitivity and selectivity. The biosensor platform consists of a silicon chip with an array of gold electrodes forming multiple sensor sites and works on the principle of electrochemical impedance spectroscopy. Each sensor site is overlaid with a biogenic nanoporous silica membrane that forms a high density of nanowells on top of each electrode. When specific protein biomarkers: C-reactive protein (CRP) and myeloperoxidase (MPO) from a test sample bind to antibodies conjugated to the surface of the gold surface at the base of each nanowell, a perturbation of electrical double layer occurs resulting in a change in the impedance. The performance of the biogenic silica membrane biosensor was tested in comparison with nanoporous alumina membrane-based biosensor and plain metallic thin film biosensor. Significant enhancement in the sensitivity and selectivity was achieved with the biogenic silica biosensor, in comparison to the other two, for detecting the two protein biomarkers from both pure and commercial human serum samples. The sensitivity of the biogenic silica biosensor is ∼1 pg/ml and the linear dose response is observed over a large dynamic range from 1 pg/ml to 1 μg/ml. Based on its performance metrics, the biogenic silica biosensor has excellent potential for development as a point of care handheld electronic biosensor device for detection of protein biomarkers from clinical samples.",
keywords = "Biogenic silica biosensor, Cardiovascular disease, Electrochemical impedance spectroscopy, Protein biomarker detection",
author = "Lin, {Kai Chun} and Vindhya Kunduru and Manish Bothara and Kaushal Rege and Shalini Prasad and Ramakrishna, {B. L.}",
year = "2010",
month = "6",
doi = "10.1016/j.bios.2010.03.032",
language = "English (US)",
volume = "25",
pages = "2336--2342",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Biogenic nanoporous silica-based sensor for enhanced electrochemical detection of cardiovascular biomarkers proteins

AU - Lin, Kai Chun

AU - Kunduru, Vindhya

AU - Bothara, Manish

AU - Rege, Kaushal

AU - Prasad, Shalini

AU - Ramakrishna, B. L.

PY - 2010/6

Y1 - 2010/6

N2 - The goal of our research is to demonstrate the feasibility of employing biogenic nanoporous silica as a key component in developing a biosensor platform for rapid label-free electrochemical detection of cardiovascular biomarkers from pure and commercial human serum samples with high sensitivity and selectivity. The biosensor platform consists of a silicon chip with an array of gold electrodes forming multiple sensor sites and works on the principle of electrochemical impedance spectroscopy. Each sensor site is overlaid with a biogenic nanoporous silica membrane that forms a high density of nanowells on top of each electrode. When specific protein biomarkers: C-reactive protein (CRP) and myeloperoxidase (MPO) from a test sample bind to antibodies conjugated to the surface of the gold surface at the base of each nanowell, a perturbation of electrical double layer occurs resulting in a change in the impedance. The performance of the biogenic silica membrane biosensor was tested in comparison with nanoporous alumina membrane-based biosensor and plain metallic thin film biosensor. Significant enhancement in the sensitivity and selectivity was achieved with the biogenic silica biosensor, in comparison to the other two, for detecting the two protein biomarkers from both pure and commercial human serum samples. The sensitivity of the biogenic silica biosensor is ∼1 pg/ml and the linear dose response is observed over a large dynamic range from 1 pg/ml to 1 μg/ml. Based on its performance metrics, the biogenic silica biosensor has excellent potential for development as a point of care handheld electronic biosensor device for detection of protein biomarkers from clinical samples.

AB - The goal of our research is to demonstrate the feasibility of employing biogenic nanoporous silica as a key component in developing a biosensor platform for rapid label-free electrochemical detection of cardiovascular biomarkers from pure and commercial human serum samples with high sensitivity and selectivity. The biosensor platform consists of a silicon chip with an array of gold electrodes forming multiple sensor sites and works on the principle of electrochemical impedance spectroscopy. Each sensor site is overlaid with a biogenic nanoporous silica membrane that forms a high density of nanowells on top of each electrode. When specific protein biomarkers: C-reactive protein (CRP) and myeloperoxidase (MPO) from a test sample bind to antibodies conjugated to the surface of the gold surface at the base of each nanowell, a perturbation of electrical double layer occurs resulting in a change in the impedance. The performance of the biogenic silica membrane biosensor was tested in comparison with nanoporous alumina membrane-based biosensor and plain metallic thin film biosensor. Significant enhancement in the sensitivity and selectivity was achieved with the biogenic silica biosensor, in comparison to the other two, for detecting the two protein biomarkers from both pure and commercial human serum samples. The sensitivity of the biogenic silica biosensor is ∼1 pg/ml and the linear dose response is observed over a large dynamic range from 1 pg/ml to 1 μg/ml. Based on its performance metrics, the biogenic silica biosensor has excellent potential for development as a point of care handheld electronic biosensor device for detection of protein biomarkers from clinical samples.

KW - Biogenic silica biosensor

KW - Cardiovascular disease

KW - Electrochemical impedance spectroscopy

KW - Protein biomarker detection

UR - http://www.scopus.com/inward/record.url?scp=77952581771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952581771&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2010.03.032

DO - 10.1016/j.bios.2010.03.032

M3 - Article

VL - 25

SP - 2336

EP - 2342

JO - Biosensors

JF - Biosensors

SN - 0956-5663

IS - 10

ER -